Loading…
Loading…
LOS ANGELES, Dec. 04, 2024 (GLOBE NEWSWIRE) -- US Nuclear Corp. (OTC: UCLE) is pleased to announce that the 3rd quarter 2024 loss was reduced to $110,971 from $760,062 in 2023, a reduction of 89%. For the nine-month period, losses were reduced from $2,296,114 in 2023, to $728,320 in 2024, a reduction of $1,567,794, or 68%.
LOS ANGELES, Nov. 19, 2024 (GLOBE NEWSWIRE) -- US Nuclear Corp. (OTC: UCLE) is pleased to announce they have made significant progress in reducing current liabilities by over $3 million in the 3rd quarter, while projecting a swing in profitability of over $1 million from the 3rd quarter of 2023. Results will be released with the 3rd quarter results later this month.
LOS ANGELES, CA, Aug. 19, 2024 (GLOBE NEWSWIRE) -- To help keep up with surging incoming purchase orders, US Nuclear Corp. (OTC: UCLE) is now significantly expanding their Overhoff (Ohio) production floor area to increase shipment volume. This is necessary due to increasingly high demand for their famous tritium monitors. This is all caused by the AI nuclear energy boom and the big money, worldwide scramble to design and build the long awaited fusion energy generators that we are all waiting for.
LOS ANGELES, CA, April 15, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- On Wednesday, April 10, 2024 the White House issued the first-ever national drinking water standard that will require water utilities to drastically reduce the levels of toxic PFAS forever chemicals down to the lowest levels that can reliably be measured. Fortunately, US Nuclear (OTC-QB: UCLE) has long been aware of the dangers of PFAS, and has already developed the world's first on-the-spot PFAS monitor that can measure PFOA and PFOS down to 1 ppt (parts per Trillion) in less than a few minutes, which is well below the EPA's limit of 4 ppt. Using US Nuclear's innovative monitors, water utilities and private well owners, can right now, on-the-spot, make the needed tests and then periodically or continuously monitor PFAS contamination thereafter, versus the time consuming and expensive process of taking each sample and sending it out to a lab for analysis.
LOS ANGELES, CA, March 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- In an exciting new update, US Nuclear's Overhoff division recently delivered the first batch of tritium monitoring systems to the nation's largest public power company. US Nuclear is proud to be a supplier for this customer, who services most of Tennessee and parts of six surrounding states, providing power for over 10 million people that is 60% carbon-free through a diverse energy portfolio. US Nuclear's tritium monitors will be used at one of the power generating stations to continuously monitor the tritium concentration in air at various locations and provide an early alarm warning if levels rise too high and protecting worker and environmental safety.
LOS ANGELES, CA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – US Nuclear's (OTC-QB: UCLE) Overhoff division has now delivered 58% of a recent $421,500 purchase contract with U.S. DOE, and expects to complete the remainder by the end of the first quarter 2024.
LOS ANGELES, CA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – With the Joint European Torus (JET) recently setting a new world record demonstrating the ability to reliably generate fusion energy using tritium and deuterium as their fuel source, and with preparations for ITER and so many other multi-million and multi-billion dollar fusion projects well underway, the use and market demand for tritium gas and tritium products are surging. US Nuclear's (OTC-QB: UCLE) Overhoff Technology branch is the go-to solution for tritium monitoring instrumentation, with over 50 years of experience manufacturing tritium monitoring products for the DOE, DOD, military, nuclear power plants, and industrial manufacturers. In fact, Overhoff is now set to complete the shipment to a U.S. DOE facility totaling $421,500 for portable monitors used for measuring tritium in air.
LOS ANGELES, CA, Feb. 12, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- On January 29, 2024, an innovative brain implant company reached a new company milestone by surgically implanting electrodes in the brain of their first human subject, thus signaling the opening of a new age and a new industry for companies such as Grapheton. US Nuclear (OTC-QB: UCLE) is proud to be Grapheton's partner and largest investor, and is incredibly excited about their potential to revolutionize therapies for disabled people of every sort. Grapheton has developed cutting-edge bioelectronic implants aimed at treating various ailments such as cardiac abnormalities, chronic pain, Parkinson's disease, and hearing loss, taking their technology a step further by using next-generation carbon-based material and multi-modal probes that read both electrical and chemical signals.